Upsher-Smith Laboratories, LLC (United States) holds 0 active US FDA Type II Drug Master Files and 1 inactive and has DMF or CEP filings on record for 1 active ingredient. 9 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Upsher-Smith Laboratories, LLC: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/upsher-smith-laboratories-llc

Overview

Upsher-Smith Laboratories, LLC is a pharmaceutical company dedicated to developing and delivering therapies to enhance health and well-being. As a subsidiary of Japan-based Sawai Pharmaceutical Co., Ltd., Upsher-Smith focuses on providing high-quality generic and branded pharmaceuticals.

Therapeutic areas

CardiovascularCNS (Central Nervous System)NeurologyWomen's Health

Active ingredients with DMF or CEP filings

Substances for which Upsher-Smith Laboratories, LLC holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Upsher-Smith Laboratories, LLC holds 0 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • NIACOR (IMMEDIATE-RELEASE NIACIN TABLETS)Inactive1993-10-07

FDA compliance signals

9 FDA enforcement records linked to this company.

  • 4832025-08-08

    Late submission of 15-day report

  • 4832025-08-08

    Failure to develop written procedures

  • recall — Class II2019-08-28

    Failed Dissolution Specifications

  • recall — Class II2018-10-31

    Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.

  • recall — Class II2018-10-31

    Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.

  • recall — Class III2014-04-30

    Labeling: Missing Label; Three cases of product (total of 36 bottles) were packaged without the primary label on the bottle. The cases were, however, packaged in the correct finished product shipper, labeled with the correct shipper bar code label, sealed with tamper-evident tape and erroneously shipped to Upsher-Smith.

  • recall — Class II2013-02-20

    Failed Dissolution Test Requirements

  • recall — Class III2013-01-23

    Labeling: Label Error On Declared Strength; Some bottles of product were missing the color-coded strength on the primary display panel of the label.

  • 4832010-04-30

    SOPs not followed / documented

For suppliers

Is this Upsher-Smith Laboratories, LLC?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.